Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/9577
Title: HIV-1-Specific Enzyme-Linked Immunosorbent Spot Assay Responses in HIV-1-Exposed Uninfected Partners in Discordant Relationships Compared to Those in Low-Risk Controls
Authors: Guthrie, Brandon L.
Lohman-Payne, Barbara
Liu, Amy Y.
Bosire, Rose
Nuvor, Samuel Victor
Choi, Robert Y.
Mackelprang, Romel D.
Kiarie, James N.
De Rosa, Stephen C.
Richardson, Barbra A.
John-Stewart, Grace C.
Keywords: HIV-1
Enzyme-Linked Immunosorbent
Uninfected Partners
Low-Risk Controls
Issue Date: 2012
Publisher: Clinical and Vaccine Immunology
Abstract: A number of studies of highly exposed HIV-1-seronegative individuals (HESN) have found HIV-1-specific cellular responses. However, there is limited evidence that responses prevent infection or are linked to HIV-1 exposure. Peripheral blood mononuclear cells (PBMC) were isolated from HESN in HIV-1-discordant relationships and low-risk controls in Nairobi, Kenya. HIV-1- specific responses were detected using gamma interferon (IFN-g) enzyme-linked immunosorbent spot (ELISpot) assays stimulated by peptide pools spanning the subtype A HIV-1 genome. The HIV-1 incidence in this HESN cohort was 1.5 per 100 person years. Positive ELISpot responses were found in 34 (10%) of 331 HESN and 14 (13%) of 107 low-risk controls (odds ratio [OR] 5 0.76; P 5 0.476). The median immunodominant response was 18.9 spot-forming units (SFU)/106 peripheral blood mononuclear cells (PBMC). Among HESN, increasing age (OR 5 1.24 per 5 years; P 5 0.026) and longer cohabitation with the HIV-1-infected partner (OR 5 5.88 per 5 years; P 5 0.003) were associated with responses. These factors were not associated with responses in controls. Other exposure indicators, including the partner’s HIV-1 load (OR 5 0.99 per log10 copy/ml; P 5 0.974) and CD4 count (OR 5 1.09 per 100 cells/ml; P 5 0.238), were not associated with responses in HESN. HIV-1-specific cellular responses may be less relevant to resistance to infection among HESN who are using risk reduction strategies that decrease their direct viral exposure
URI: http://hdl.handle.net/123456789/9577
Appears in Collections:School of Medical Sciences

Files in This Item:
File Description SizeFormat 
Clinical and Vaccine Immunology-2012-Guthrie-1798.full.pdfMAIN ARTICLE257.62 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.